Institut de Génétique et de Biologie Moléculaire et Cellulaire, UMR 7104 CNRS UDS - U 964 INSERM, 1 Rue Laurent Fries, BP 10142, 67404 Illkirch cedex, Graffenstaden, France.
Br J Cancer. 2010 Aug 24;103(5):715-26. doi: 10.1038/sj.bjc.6605823. Epub 2010 Jul 27.
Head and neck squamous cell carcinoma (HNSCC) is associated with poor survival. To identify prognostic and diagnostic markers and therapeutic targets, we studied ANO1, a recently identified calcium-activated chloride channel (CaCC).
High-resolution genomic and transcriptomic microarray analysis and functional studies using HNSCC cell line and CaCC inhibitors.
Amplification and overexpression of genes within the 11q13 amplicon are associated with the propensity for future distance metastasis of HPV-negative HNSCC. ANO1 was selected for functional studies based on high correlations, cell surface expression and CaCC activity. ANO1 overexpression in cells that express low endogenous levels stimulates cell movement, whereas downregulation in cells with high endogenous levels has the opposite effect. ANO1 overexpression also stimulates attachment, spreading, detachment and invasion, which could account for its effects on migration. CaCC inhibitors decrease movement, suggesting that channel activity is required for the effects of ANO1. In contrast, ANO1 overexpression does not affect cell proliferation.
ANO1 amplification and expression could be markers for distant metastasis in HNSCC. ANO1 overexpression affects cell properties linked to metastasis. Inhibitors of CaCCs could be used to inhibit the tumourigenic properties of ANO1, whereas activators developed to increase CaCC activity could have adverse effects.
头颈部鳞状细胞癌(HNSCC)与预后不良相关。为了确定预后和诊断标志物以及治疗靶点,我们研究了最近发现的钙激活氯离子通道(CaCC)ANO1。
使用 HNSCC 细胞系和 CaCC 抑制剂进行高分辨率基因组和转录组微阵列分析和功能研究。
11q13 扩增子内基因的扩增和过表达与 HPV 阴性 HNSCC 未来远处转移的倾向相关。ANO1 基于高相关性、细胞表面表达和 CaCC 活性被选为功能研究的对象。在表达低内源性水平的细胞中过表达 ANO1 可刺激细胞运动,而在高内源性水平的细胞中下调则有相反的效果。ANO1 的过表达还刺激附着、扩展、分离和侵袭,这可以解释其对迁移的影响。CaCC 抑制剂可降低运动,表明通道活性是 ANO1 作用所必需的。相比之下,ANO1 的过表达不会影响细胞增殖。
ANO1 扩增和表达可能是 HNSCC 远处转移的标志物。ANO1 的过表达会影响与转移相关的细胞特性。CaCC 抑制剂可用于抑制 ANO1 的致瘤特性,而开发的激活剂可增加 CaCC 活性,可能会产生不利影响。